MedTrace Logo

The Effect of Early Switching From Intravenous to Oral Antibiotics Therapy

NCT04781439 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2021-03-04

No results posted yet for this study

Summary

To date, many studies showed the great benefits of switching from IV to PO antibiotics in some infectious diseases, especially skin and soft tissue, urinary tract, respiratory tract, gallbladder, and biliary tract infection. Higher level of evidence is necessary to confirm the benefit of early switching protocol in infectious condition management. Therefore, we conducted a clinical trial to investigate the effectiveness and cost of IV-to-PO antibiotic switch therapy in some surgical infection conditions.

Conditions

  • Skin and Subcutaneous Tissue Infection

Interventions

PROCEDURE

IV-to-PO conversion of antibiotics

IV-to-PO switching of antibiotics treatment

Sponsors & Collaborators

  • Gia Dinh People Hospital

    lead OTHER

Principal Investigators

  • Dung Nguyen, PhD · Gia Dinh People Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2020-08-30
Completion
2020-09-29

Countries

  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04781439 on ClinicalTrials.gov